Latest Articles
IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy - Yahoo Finance
IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy Yahoo Finance
Published: Sept. 4, 2025, 12:30 p.m.
IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy - PR Newswire
IceCure's ProSense® Substantially Reduces Abdominal Wall Endometriosis Pain with High Procedural Efficacy PR Newswire
Published: Sept. 4, 2025, 12:30 p.m.
The Efficacy of Acupuncture on Endometrial Receptivity in Infertile Women: An overview of Systematic Review and Meta-Analysis - Frontiers
The Efficacy of Acupuncture on Endometrial Receptivity in Infertile Women: An overview of Systematic Review and Meta-Analysis Frontiers
Published: Aug. 8, 2025, 4:52 p.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Comparison of the Efficacy of Single vs. Double Autologous Platelet-Rich Plasma (PRP) Intrauterine Infusion on Endometrial Receptivity in Thin Endometrium Patients: A Prospective Randomized Controlled Trial - Frontiers
Comparison of the Efficacy of Single vs. Double Autologous Platelet-Rich Plasma (PRP) Intrauterine Infusion on Endometrial Receptivity in Thin Endometrium Patients: A Prospective Randomized Controlled Trial Frontiers
Published: July 30, 2025, 7:34 p.m.
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights - Cureus
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights Cureus
Published: July 30, 2025, 7:21 a.m.
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer - OncLive
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer OncLive
Published: July 24, 2025, 2:03 p.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive
Published: July 24, 2025, 1:49 p.m.
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment - TipRanks
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment TipRanks
Published: May 23, 2025, 10:59 a.m.
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma - OncLive
Second Immunotherapy Exposure: Understanding Efficacy and Safety in Endometrial and Cervical Carcinoma OncLive
Published: April 28, 2025, 1:18 p.m.
Link copied to clipboard!